Aeterna Zentaris Abstract Accepted for Presentation at

– Company advancing development of its Autoimmunity Modifying AIM Biologicals as a potential therapeutic treatment option for Parkinson’s Disease ("PD"), a...

Related Keywords

United States ,Portland ,Oregon ,Toronto ,Ontario ,Canada ,Oregon Convention Center ,American ,Chi Wang Ip ,Joerg Wischhusen ,Klaus Paulini ,Valentin Bruttel ,Event Of The American Association Immunologists ,School Of Medicine ,Department Of Obstetrics ,Aeterna Zentaris ,Department Of Neurology ,Nasdaq ,University Of Wuerzburg The ,Aeterna Zentaris Inc ,Autoimmunity Modifying ,Annual Event ,American Association ,Experimental Tumor Immunology ,Therapeutic Approaches ,Based Therapeutics ,Chief Executive Officer ,Nasdaq Aezs ,Tsezs ,Mmunology2022 ,Im Biologicals ,Diagnostic Products ,Parkinsons Disease ,Iopharmaceutical ,Medicine ,